Emcure Pharmaceuticals Ltd

EMCURE

Company Profile

  • Business description

    Emcure Pharmaceuticals Ltd an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals including solids, liquid orals and dry syrup/suspensions., injectables such as vials and pre-filled syringes, and forms such as lyophilized & liquid and biotherapeutics. The company operates in Derma, Women’s Health, Cardiovascular, Neurology, Oncology, Vaccines, and Anti-infectives. Geographically, it operates in India, Europe, Canada, Vietnam, Dubai, and Other Countries.

  • Contact

    Plot No. P-1 and P-2, IT-BT Park
    Phase II, M.I.D.C.
    Hinjawadi
    PuneMH411 057
    IND

    T: +91 2035070033

    https://www.emcure.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2026

    Employees

    11,474

Stocks News & Analysis

stocks

Are we as bullish on Oracle as the market?

Shares jumped in response to the latest results.
stocks

Anglo American strikes deal to create a new copper giant

We are surprised that Teck agreed to the merger on these terms, and wouldn’t be surprised if there is a twist in the tale.
stocks

The ‘other’ AI chip behemoth that might just be getting started

The magnitude of growth at Broadcom continues to astound us.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,063.7016.80-0.19%
CAC 407,761.3211.930.15%
DAX 4023,632.9585.50-0.36%
Dow JONES (US)45,490.92220.42-0.48%
FTSE 1009,225.3917.14-0.19%
HKSE26,106.4093.86-0.36%
NASDAQ21,886.066.570.03%
Nikkei 22544,126.28288.610.66%
NZX 50 Index13,213.1663.08-0.48%
S&P 5006,532.0419.430.30%
S&P/ASX 2008,797.1016.70-0.19%
SSE Composite Index3,852.0139.791.04%

Market Movers